CalciMedica files prospectus supplement for up to $25 million at-the-market stock offering
CALC•CalciMedica launched an at-the-market equity program to sell up to $25 million of common stock under its existing equity distribution agreement and effective Form S-3 shelf registration statement.
1. Offering details
CalciMedica launched an at-the-market equity program to sell up to $25 million of common stock. Sales may occur from time to time under its existing equity distribution agreement with H.C. Wainwright, using the company’s effective Form S-3 shelf registration statement.
